{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:15:49Z","timestamp":1772752549884,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-0914"],"award-info":[{"award-number":["IIRP-2023-0914"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","award":["A-1028"],"award-info":[{"award-number":["A-1028"]}],"id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation","doi-asserted-by":"publisher","award":["CRG\/2023\/001373"],"award-info":[{"award-number":["CRG\/2023\/001373"]}],"id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152351","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:29:41Z","timestamp":1752625781000},"page":"152351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Overcoming paclitaxel resistance in ovarian cancer cells using DN200434, an inverse agonist of estrogen-related receptor gamma (ERR\u03b3)"],"prefix":"10.1016","volume":"778","author":[{"given":"Ridhima","family":"Goel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachita","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Gulwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-9136","authenticated-orcid":false,"given":"Thoudam Debraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152351_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114205","article-title":"Therapeutic strategies to overcome cisplatin resistance in ovarian cancer","volume":"232","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152351_bib2","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/cancers14122885","article-title":"Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review","volume":"14","author":"Liberto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2025.152351_bib3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.21037\/gs-20-325","article-title":"Secondary and tertiary ovarian cancer recurrence: what is the best management?","volume":"9","author":"Garzon","year":"2020","journal-title":"Gland Surg."},{"key":"10.1016\/j.bbrc.2025.152351_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of gynecologic oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2025.152351_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152351_bib6","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.3390\/ijms22179451","article-title":"Battling chemoresistance in cancer: root causes and strategies to uproot them","volume":"22","author":"Ramos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152351_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/413076","article-title":"Paclitaxel and its evolving role in the management of ovarian cancer","volume":"2015","author":"Kampan","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbrc.2025.152351_bib8","first-page":"187","article-title":"Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer","volume":"15","author":"Fennelly","year":"1997","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.bbrc.2025.152351_bib9","first-page":"1320","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"Du Bois","year":"2003","journal-title":"Cancer Spect. Knowl. Environ."},{"key":"10.1016\/j.bbrc.2025.152351_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84791","article-title":"Structural insight into the stabilization of microtubules by taxanes","volume":"12","author":"Prota","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.bbrc.2025.152351_bib11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2025.152351_bib12","doi-asserted-by":"crossref","first-page":"12902","DOI":"10.1074\/jbc.M414477200","article-title":"\u03b2III-Tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability","volume":"280","author":"Kamath","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152351_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2025.152351_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0360-3016(99)00109-1","article-title":"Paclitaxel sensitivity correlates with P53 status and DNA fragmentation, but not G2\/M accumulation","volume":"44","author":"Rakovitch","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrc.2025.152351_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2025.152351_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.152351_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/aps.2014.121","article-title":"The multiple universes of estrogen-related receptor \u03b1 and \u03b3 in metabolic control and related diseases","volume":"36","author":"Audet-Walsh","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2025.152351_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202400192","article-title":"Estrogen\u2010related receptor gamma (ERR\u03b3) as biomarker and novel target for therapeutic intervention on cancer: a review","volume":"7","author":"Upadhyay","year":"2024","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.bbrc.2025.152351_bib19","doi-asserted-by":"crossref","first-page":"21628","DOI":"10.1074\/jbc.M111.315168","article-title":"Orphan nuclear receptor estrogen-related receptor \u03b3 (ERR\u03b3) is key regulator of hepatic gluconeogenesis","volume":"287","author":"Kim","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152351_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5483\/BMBRep.2022.55.11.089","article-title":"DN200434, an orally available inverse agonist of estrogen-related receptor \u03b3, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma","volume":"55","author":"Kim","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbrc.2025.152351_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.115","article-title":"Estrogen-related receptor \u03b3 is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27","volume":"48","author":"Kim","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152351_bib22","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00432-021-03673-9","article-title":"Expression of estrogen-related receptors in ovarian cancer and impact on survival","volume":"147","author":"Sch\u00fcler-Toprak","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152351_bib23","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1158\/1078-0432.CCR-18-3007","article-title":"A novel orally active inverse agonist of estrogen-related receptor gamma (ERR\u03b3), DN200434, A booster of NIS in anaplastic thyroid cancer","volume":"25","author":"Singh","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152351_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.31557\/APJCP.2023.24.2.375","article-title":"Unfolding of imminent bio-signatures in the prognosis of thyroid cancer; the emergence of estrogen related receptor gamma (ERR\u03b3) as a hurricane","volume":"24","author":"Gulwani","year":"2023","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrc.2025.152351_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00109-005-0639-3","article-title":"Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells","volume":"83","author":"Sun","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152351_bib26","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s44321-024-00108-z","article-title":"Therapeutic targeting ERR\u03b3 suppresses metastasis via extracellular matrix remodeling in small cell lung cancer","volume":"16","author":"Wang","year":"2005","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152351_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/or.2018.6471","article-title":"Estrogen-related receptor \u03b3 promotes the migration and metastasis of endometrial cancer cells by targeting S100A4","volume":"40","author":"Hua","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2025.152351_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104676","article-title":"High bisphenol A concentrations augment the invasiveness of tumor cells through Snail-1\/Cx43\/ERR\u03b3-dependent epithelial-mesenchymal transition","volume":"62","author":"Ryszawy","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.bbrc.2025.152351_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","article-title":"Wnt\/\u03b2-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis","volume":"12","author":"Nguyen","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.bbrc.2025.152351_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152351_bib31","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.18632\/oncotarget.15687","article-title":"The regulation of \u03b2-catenin activity and function in cancer: therapeutic opportunities","volume":"8","author":"Shang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.152351_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.152351_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123664","article-title":"Unsung versatility of elastin-like polypeptide inspired spheroid fabrication: a review","volume":"234","author":"Goel","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2025.152351_bib34","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-018-04244-2","article-title":"Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer","volume":"9","author":"Kang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152351_bib35","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1158\/0008-5472.CAN-06-3855","article-title":"ERR suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152351_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2017.102","article-title":"Nuclear receptors in cancer \u2014 uncovering new and evolving roles through genomic analysis","volume":"19","author":"Dhiman","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2025.152351_bib37","doi-asserted-by":"crossref","DOI":"10.1210\/er.2018-00222","article-title":"Nuclear receptors: recent drug discovery for cancer therapies","author":"Zhao","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2025.152351_bib38","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/0008-5472.CAN-10-1315","article-title":"Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth","volume":"71","author":"Tiraby","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152351_bib39","first-page":"1","article-title":"ERR\u03b3, a novel biomarker, associates with pathoglycemia of endometrial cancer to predict myometrial invasion","volume":"2022","author":"Tong","year":"2022","journal-title":"J. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25010666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25010666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:32:22Z","timestamp":1772749942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25010666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"alternative-id":["S0006291X25010666"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152351","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming paclitaxel resistance in ovarian cancer cells using DN200434, an inverse agonist of estrogen-related receptor gamma (ERR\u03b3)","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152351"}}